On May 6, 2024, the Compensation Committee of Abeona’s Board of Directors granted restricted stock equity awards as a ...

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, ...

INOVIO Pharmaceuticals Inc. (NASDAQ: INO) has announced the recent award of equity grants to two new employees as part of its 2022 Inducement Plan. The company’s ...

Neuronetics, Inc. (NASDAQ: STIM), a medical technology firm, awarded Restricted Stock Units (RSUs) equivalent to 55,650 ...

The awards were approved by the Compensation Committee of Ocular and were made as inducements material to each individual’s acceptance of employment with Ocular under Ocular’s 2019 Inducement Stock ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform ...

Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective May 1, 2024, the Compensation Committee of ...

The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the ...

The awards were approved by the Compensation Committee of Ocular and were made as inducements material to each individual's acceptance of employment with Ocular under Ocular's 2019 Inducement Stock ...

The Compensation Committee approved the equity awards as an inducement material to Mr. Joshi’s employment in accordance with Nasdaq Listing Rule 5635(c)(4). The terms of the inducement awards are ...

The 2020 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Blueprint Medicines, as an inducement ...